This article was originally published on ETFTrends.com.
The biotech sector performed well in August, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) up almost 3.5% this week alone. Research by Raymond James indicates that in just the past week, biotech funds saw $510 million in capital inflows. This in part led major biotech companies like Biogen Inc (NASDAQ: BIIB) and Celgene Corp (NASDAQ: [...]
Continue Reading Below